K-numberK240435
Device nameAlpha Dent Implants Dental Implants System
ApplicantAlpha Dent Implants GmbH
Product codeDZE
Device classClass II
Decision dateDec 20, 2024
DecisionSubstantially Equivalent
Regulation872.3640
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Alpha Dent Implants Dental Implants System is intended for surgical placement in the upper or lower jaw to support crowns, bridges, or dentures in patients without teeth. It restores chewing function and can support single or multiple teeth. The system is indicated for immediate loading when good primary stability is achieved with appropriate occlusal loading.

Technological characteristics

The implants are tapered, threaded root-form implants manufactured from Grade 4 commercially pure titanium (Ti CP4) with a sandblasted, large-grit, acid-etched (SLA) surface treatment. They feature a conical connection with a 2.1 mm hexagon platform and come in diameters from 3.3–6.0 mm and lengths from 8–13 mm. The implants are packaged wet in isotonic sodium chloride (0.9% NaCl) solution within a titanium protective sleeve.

Test standards cited

ISO 14801:2016 (dynamic fatigue testing), ISO 10993-1:2018 (biocompatibility), ISO 10993-5:2009 (cytotoxicity), ASTM F67-13 and F136-13 (titanium material specifications), ASTM F-1980 (accelerated aging), ANSI/AAMI/ISO 11137-1 and EN ISO 11137-2 (sterilization validation), ISO 11607-1:2019 (packaging), USP<85> and ANSI/AAMI ST72 (pyrogenicity via LAL method).

Substantial equivalence argument

Substantial equivalence is based on identical intended use, device classification, implant/abutment connection design, platform diameter, and surface treatment (SLA) compared to the primary predicate K210499 (Alpha Dent Implants). Although the subject devices use Ti Grade 4 instead of Grade 5, mechanical testing per ISO 14801 on worst-case scenarios (25° abutment angulation, 3.3 mm diameter) confirmed equivalent performance. Biocompatibility testing per ISO 10993-1 for the Ti Grade 4 material, supplemented by hydrophilicity and cytotoxicity studies on aged implants, demonstrated safety equivalent to the predicate. The wet packaging in NaCl 0.9%, gamma irradiation sterilization, and support for immediate loading further establish substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →